Research ExplorerPublicationsComparison of three clinical rating scales in Friedreich ata...

Comparison of three clinical rating scales in Friedreich ataxia (FRDA).

Standard

Comparison of three clinical rating scales in Friedreich ataxia (FRDA). / Bürk, Katrin; Mälzig, Ulrike; Wolf, Stefanie; Heck, Suzette; Dimitriadis, Konstantinos; Schmitz-Hübsch, Tanja; Hering, Sascha; Lindig, Tobias M; Haug, Verena; Timmann, Dagmar; Degen, Ingrid; Kruse, Bernd; Dörr, Jan-Markus; Ratzka, Susanne; Ivo, Anja; Schöls, Ludger; Boesch, Sylvia; Klockgether, Thomas; Klopstock, Thomas; Schulz, Jörg B.

In: MOVEMENT DISORD, 2009.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Bürk, K, Mälzig, U, Wolf, S, Heck, S, Dimitriadis, K, Schmitz-Hübsch, T, Hering, S, Lindig, TM, Haug, V, Timmann, D, Degen, I, Kruse, B, Dörr, J-M, Ratzka, S, Ivo, A, Schöls, L, Boesch, S, Klockgether, T, Klopstock, T & Schulz, JB 2009, 'Comparison of three clinical rating scales in Friedreich ataxia (FRDA).', MOVEMENT DISORD. <http://www.ncbi.nlm.nih.gov/pubmed/19562766?dopt=Citation>

APA

Bürk, K., Mälzig, U., Wolf, S., Heck, S., Dimitriadis, K., Schmitz-Hübsch, T., Hering, S., Lindig, T. M., Haug, V., Timmann, D., Degen, I., Kruse, B., Dörr, J-M., Ratzka, S., Ivo, A., Schöls, L., Boesch, S., Klockgether, T., Klopstock, T., & Schulz, J. B. (2009). Comparison of three clinical rating scales in Friedreich ataxia (FRDA). MOVEMENT DISORD. http://www.ncbi.nlm.nih.gov/pubmed/19562766?dopt=Citation

Vancouver

Bürk K, Mälzig U, Wolf S, Heck S, Dimitriadis K, Schmitz-Hübsch T et al. Comparison of three clinical rating scales in Friedreich ataxia (FRDA). MOVEMENT DISORD. 2009.

Bibtex

@article{83e13621ff474bd68ce9a0f10de99697,
title = "Comparison of three clinical rating scales in Friedreich ataxia (FRDA).",
abstract = "To test the validity and reliability of the scale for the assessment and rating of ataxia (SARA) in Friedreich ataxia (FRDA). SARA is limited to eight items and can be performed rapidly. Ninety-six patients with a molecular genetic diagnosis of FRDA were rated using three different clinical scales, the FRDA Rating Scale (FARS), the International Cooperative Ataxia Rating Scale (ICARS), and SARA. Despite considerable discrepancies in scale size and subscale structure, SARA total scores were significantly correlated with ICARS (r = 0.953, P <0.0001) and FARS (r = 0.938, P <0.0001) total scores. SARA total scores also correlated with the activities of daily living (ADL, r = 0.929, P <0.0001). Although originally developed for the use in dominantly inherited ataxias, which are primarily ataxias of the cerebellar type, SARA can also be used successfully to assess afferent ataxia, which is the predominant form in FRDA. Because SARA is characterized by high interrater reliability and practicability, SARA is applicable and well suited forclinical trials of FRDA. (c) 2009 Movement Disorder Society.",
author = "Katrin B{\"u}rk and Ulrike M{\"a}lzig and Stefanie Wolf and Suzette Heck and Konstantinos Dimitriadis and Tanja Schmitz-H{\"u}bsch and Sascha Hering and Lindig, {Tobias M} and Verena Haug and Dagmar Timmann and Ingrid Degen and Bernd Kruse and Jan-Markus D{\"o}rr and Susanne Ratzka and Anja Ivo and Ludger Sch{\"o}ls and Sylvia Boesch and Thomas Klockgether and Thomas Klopstock and Schulz, {J{\"o}rg B}",
year = "2009",
language = "English",
journal = "MOVEMENT DISORD",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",

}

RIS

TY - JOUR

T1 - Comparison of three clinical rating scales in Friedreich ataxia (FRDA).

AU - Bürk, Katrin

AU - Mälzig, Ulrike

AU - Wolf, Stefanie

AU - Heck, Suzette

AU - Dimitriadis, Konstantinos

AU - Schmitz-Hübsch, Tanja

AU - Hering, Sascha

AU - Lindig, Tobias M

AU - Haug, Verena

AU - Timmann, Dagmar

AU - Degen, Ingrid

AU - Kruse, Bernd

AU - Dörr, Jan-Markus

AU - Ratzka, Susanne

AU - Ivo, Anja

AU - Schöls, Ludger

AU - Boesch, Sylvia

AU - Klockgether, Thomas

AU - Klopstock, Thomas

AU - Schulz, Jörg B

PY - 2009

Y1 - 2009

N2 - To test the validity and reliability of the scale for the assessment and rating of ataxia (SARA) in Friedreich ataxia (FRDA). SARA is limited to eight items and can be performed rapidly. Ninety-six patients with a molecular genetic diagnosis of FRDA were rated using three different clinical scales, the FRDA Rating Scale (FARS), the International Cooperative Ataxia Rating Scale (ICARS), and SARA. Despite considerable discrepancies in scale size and subscale structure, SARA total scores were significantly correlated with ICARS (r = 0.953, P <0.0001) and FARS (r = 0.938, P <0.0001) total scores. SARA total scores also correlated with the activities of daily living (ADL, r = 0.929, P <0.0001). Although originally developed for the use in dominantly inherited ataxias, which are primarily ataxias of the cerebellar type, SARA can also be used successfully to assess afferent ataxia, which is the predominant form in FRDA. Because SARA is characterized by high interrater reliability and practicability, SARA is applicable and well suited forclinical trials of FRDA. (c) 2009 Movement Disorder Society.

AB - To test the validity and reliability of the scale for the assessment and rating of ataxia (SARA) in Friedreich ataxia (FRDA). SARA is limited to eight items and can be performed rapidly. Ninety-six patients with a molecular genetic diagnosis of FRDA were rated using three different clinical scales, the FRDA Rating Scale (FARS), the International Cooperative Ataxia Rating Scale (ICARS), and SARA. Despite considerable discrepancies in scale size and subscale structure, SARA total scores were significantly correlated with ICARS (r = 0.953, P <0.0001) and FARS (r = 0.938, P <0.0001) total scores. SARA total scores also correlated with the activities of daily living (ADL, r = 0.929, P <0.0001). Although originally developed for the use in dominantly inherited ataxias, which are primarily ataxias of the cerebellar type, SARA can also be used successfully to assess afferent ataxia, which is the predominant form in FRDA. Because SARA is characterized by high interrater reliability and practicability, SARA is applicable and well suited forclinical trials of FRDA. (c) 2009 Movement Disorder Society.

M3 - SCORING: Journal article

JO - MOVEMENT DISORD

JF - MOVEMENT DISORD

SN - 0885-3185

ER -